Selected article for: "ARDS patient and ECMO extracorporeal membrane oxygenation"
Author: Chang, Ko-Wei; Lee, Kuang-Tso; Lo, Yu-Lun; Hu, Han-Chung; Yang, Cheng-Ta; Lin, Shu-Min
Title: Successful Management of COVID-19 Induced Acute Respiratory Distress Syndrome by Extracorporeal Membrane Oxygenation with 1-year follow-up: A Case Report
  • Cord-id: rlfdn3cs
  • Document date: 2021_9_3
    • ID: rlfdn3cs
    Snippet: Coronavirus 2019 (referred to as COVID-19) has infected millions of people throughout the world. This paper reports on a case of COVID-19-induced acute respiratory distress syndrome (ARDS) in which the patient was administered extracorporeal membrane oxygenation (ECMO) to deal with refractory hypoxia. The patient recovered from ARDS following ECMO treatment. In 1-year follow-up, the muscle weakness persisted, and the pulmonary vital capacity recovered sooner than diffusion capacity.
    Document: Coronavirus 2019 (referred to as COVID-19) has infected millions of people throughout the world. This paper reports on a case of COVID-19-induced acute respiratory distress syndrome (ARDS) in which the patient was administered extracorporeal membrane oxygenation (ECMO) to deal with refractory hypoxia. The patient recovered from ARDS following ECMO treatment. In 1-year follow-up, the muscle weakness persisted, and the pulmonary vital capacity recovered sooner than diffusion capacity.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and long term outcome: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung injury prevent: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung protect: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and lung protective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung protective ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung protective ventilation strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte count crp: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lymphocyte count low: 1, 2
    • acute ards respiratory distress syndrome develop and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome develop and lung protective: 1, 2, 3
    • acute ards respiratory distress syndrome develop and lung protective ventilation: 1, 2, 3
    • acute ards respiratory distress syndrome develop and lung tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome develop and lymphocyte count: 1, 2
    • acute ards respiratory distress syndrome develop and lymphocyte count crp: 1, 2
    • long term outcome and lung protective ventilation: 1, 2
    • long term outcome and lung tissue: 1